Point your AI agent at freehire and let it find you a job.

Get the CLI →

Padagis

Develops and manufactures generic prescription topical pharmaceutical products.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
healthcarepharmaceuticals

Company facts

Founded
2004
Employees
1,300
Headquarters
United States
CEO
Pamela Hoffman
Type
Private
Funding
Private Equity · $1.6B · 2021
Subsidiaries
Padagis Israel

About

At Padagis, we are dedicated to expanding access to high-quality, affordable medications that support better health outcomes. Founded with the vision that every patient deserves affordable access to the medication that best serves their needs, we have grown into a leading global provider of generic pharmaceuticals. Our dedicated team, operating across the U.S. and Israel, is committed to innovation and excellence, ensuring that our products meet rigorous safety and efficacy standards while remaining accessible to all. With a focus on topical and other non-oral pharmaceutical products, we manufacture a broad range of prescription and over-the-counter treatments including prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories. We specialize in Paragraph IV products, developing and manufacturing treatments that focus on the complexities of branded pharmaceutical patents. Padagis is at the forefront of reducing healthcare costs and improving accessibility, with a strong focus on life-saving products like Naloxone Nasal Spray to combat the opioid crisis. Our commitment to innovation, reliability, and reducing healthcare costs helps patients and healthcare providers get the care they need with confidence.

4 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.